Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

Mon, 29 Jun 2026 08:00:00 -0400

Marks a major milestone in expanding access to this next-generation intravascular imaging technology, helping physicians make more informed decisions across a wide range of coronary interventions
Addresses the need to balance the deep vessel visualization of IVUS with the high-resolution surface detail of OFDI

SOMERSET, N.J., June 29, 2026 /PRNewswire/ -- Terumo Interventional Systems (TIS), a division of Terumo Corporation, recently completed the first procedure using its OPUSWAVE^® Dual Sensor Imaging System. The procedure, performed on June 15 by Annapoorna S. Kini, MD, MRCP, FACC, at Mount Sinai Fuster Heart Hospital in

Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

Mon, 29 Jun 2026 08:00:00 -0400

Marks a major milestone in expanding access to this next-generation intravascular imaging technology, helping physicians make more informed decisions across a wide range of coronary interventions
Addresses the need to balance the deep vessel visualization of IVUS with the high-resolution surface detail of OFDI

Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

Mon, 29 Jun 2026 08:00:00 -0400

Marks a major milestone in expanding access to this next-generation intravascular imaging technology, helping physicians make more informed decisions across a wide range of coronary interventions
Addresses the need to balance the deep vessel visualization of IVUS with the high-resolution surface detail of OFDI

Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

Mon, 29 Jun 2026 08:00:00 -0400

Marks a major milestone in expanding access to this next-generation intravascular imaging technology, helping physicians make more informed decisions across a wide range of coronary interventions
Addresses the need to balance the deep vessel visualization of IVUS with the high-resolution surface detail of OFDI

Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

Mon, 29 Jun 2026 08:00:00 -0400

Marks a major milestone in expanding access to this next-generation intravascular imaging technology, helping physicians make more informed decisions across a wide range of coronary interventions
Addresses the need to balance the deep vessel visualization of IVUS with the high-resolution surface detail of OFDI

Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

Mon, 29 Jun 2026 08:00:00 -0400

Marks a major milestone in expanding access to this next-generation intravascular imaging technology, helping physicians make more informed decisions across a wide range of coronary interventions
Addresses the need to balance the deep vessel visualization of IVUS with the high-resolution surface detail of OFDI

Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

Mon, 29 Jun 2026 08:00:00 -0400

Marks a major milestone in expanding access to this next-generation intravascular imaging technology, helping physicians make more informed decisions across a wide range of coronary interventions
Addresses the need to balance the deep vessel visualization of IVUS with the high-resolution surface detail of OFDI

Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

Mon, 29 Jun 2026 08:00:00 -0400

Marks a major milestone in expanding access to this next-generation intravascular imaging technology, helping physicians make more informed decisions across a wide range of coronary interventions
Addresses the need to balance the deep vessel visualization of IVUS with the high-resolution surface detail of OFDI

Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

Mon, 29 Jun 2026 08:00:00 -0400

Marks a major milestone in expanding access to this next-generation intravascular imaging technology, helping physicians make more informed decisions across a wide range of coronary interventions
Addresses the need to balance the deep vessel visualization of IVUS with the high-resolution surface detail of OFDI

Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

Mon, 29 Jun 2026 08:00:00 -0400

Marks a major milestone in expanding access to this next-generation intravascular imaging technology, helping physicians make more informed decisions across a wide range of coronary interventions
Addresses the need to balance the deep vessel visualization of IVUS with the high-resolution surface detail of OFDI

Terumo Corp. (4543:JP) (TRUMY) PT Raised to JPY2,700 at JPMorgan

Mon, 22 Jun 2026 06:50:57 -0400

JPMorgan analyst Naoko Saito raised the price target on Terumo Corp. (4543:JP) (OTC: TRUMY) to JPY2,700.00 (from JPY2,500.00) while maintaining a Overweight rating.

Terumo Corp. (4543:JP) (TRUMY) PT Raised to JPY2,700 at JPMorgan

Mon, 22 Jun 2026 06:50:57 -0400

JPMorgan analyst Naoko Saito raised the price target on Terumo Corp. (4543:JP) (OTC: TRUMY) to JPY2,700.00 (from JPY2,500.00) while maintaining a Overweight rating.

Terumo Corp. (4543:JP) (TRUMY) PT Raised to JPY2,700 at JPMorgan

Mon, 22 Jun 2026 06:50:57 -0400

JPMorgan analyst Naoko Saito raised the price target on Terumo Corp. (4543:JP) (OTC: TRUMY) to JPY2,700.00 (from JPY2,500.00) while maintaining a Overweight rating.

Terumo Corp. (4543:JP) (TRUMY) PT Raised to JPY2,700 at JPMorgan

Mon, 22 Jun 2026 06:50:57 -0400

JPMorgan analyst Naoko Saito raised the price target on Terumo Corp. (4543:JP) (OTC: TRUMY) to JPY2,700.00 (from JPY2,500.00) while maintaining a Overweight rating.

Goldman Sachs Reiterates Neutral Rating on Terumo Corp. (4543:JP) (TRUMY)

Tue, 16 Jun 2026 00:22:43 -0400

Goldman Sachs analyst Akinori Ueda reiterated a Neutral rating and JPY2,400.00 price target on Terumo Corp. (4543:JP) (OTC: TRUMY).

Goldman Sachs Reiterates Neutral Rating on Terumo Corp. (4543:JP) (TRUMY)

Tue, 16 Jun 2026 00:22:43 -0400

Goldman Sachs analyst Akinori Ueda reiterated a Neutral rating and JPY2,400.00 price target on Terumo Corp. (4543:JP) (OTC: TRUMY).

Terumo Corp. (4543:JP) (TRUMY) PT Raised to JPY3,300 at Citi

Wed, 27 May 2026 05:32:52 -0400

Citi analyst Hidemaru Yamaguchi raised the price target on Terumo Corp. (4543:JP) (OTC: TRUMY) to JPY3,300.00 (from JPY3,000.00) while maintaining a Buy rating.

Terumo Corp. (4543:JP) (TRUMY) PT Raised to JPY3,300 at Citi

Wed, 27 May 2026 05:32:52 -0400

Citi analyst Hidemaru Yamaguchi raised the price target on Terumo Corp. (4543:JP) (OTC: TRUMY) to JPY3,300.00 (from JPY3,000.00) while maintaining a Buy rating.

Terumo Corp. (4543:JP) (TRUMY) PT Raised to JPY3,300 at Citi

Wed, 27 May 2026 05:32:52 -0400

Citi analyst Hidemaru Yamaguchi raised the price target on Terumo Corp. (4543:JP) (OTC: TRUMY) to JPY3,300.00 (from JPY3,000.00) while maintaining a Buy rating.

Terumo Corp. (4543:JP) (TRUMY) PT Raised to JPY3,300 at Citi

Wed, 27 May 2026 05:32:52 -0400

Citi analyst Hidemaru Yamaguchi raised the price target on Terumo Corp. (4543:JP) (OTC: TRUMY) to JPY3,300.00 (from JPY3,000.00) while maintaining a Buy rating.

OrganOx Announces Appointment of Naoya Iwata as CEO & President

Thu, 14 May 2026 08:00:00 -0400

OXFORD, United Kingdom and MADISON, N.J., May 14, 2026 (GLOBE NEWSWIRE) -- OrganOx, a wholly owned subsidiary of Terumo Corporation, today announced the appointment of Naoya Iwata as Chief Executive Officer & President, effective June 1, 2026. With more than two decades of international leadership experience at Terumo Corporation spanning sales, marketing, strategic planning, and business development, Iwata brings deep expertise in scaling global medical technology organizations and driving commercial growth. Most recently serving as Chief of Staff to Terumo Chief Executive Officer Hikaru Samejima, Iwata has played a key role in advancing strategic initiatives across the Terumo

OrganOx Announces Appointment of Naoya Iwata as CEO & President

Thu, 14 May 2026 08:00:00 -0400

OrganOx Announces Appointment of Naoya Iwata as CEO & President

Thu, 14 May 2026 08:00:00 -0400

OrganOx Announces Appointment of Naoya Iwata as CEO & President

Thu, 14 May 2026 08:00:00 -0400

OrganOx Announces Appointment of Naoya Iwata as CEO & President

Thu, 14 May 2026 08:00:00 -0400

StreetInsider.com News Articles

Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

Terumo Interventional Systems Announces First Procedure Using Its OPUSWAVE® Dual Sensor Imaging System in the United States

Terumo Corp. (4543:JP) (TRUMY) PT Raised to JPY2,700 at JPMorgan

Terumo Corp. (4543:JP) (TRUMY) PT Raised to JPY2,700 at JPMorgan

Terumo Corp. (4543:JP) (TRUMY) PT Raised to JPY2,700 at JPMorgan

Terumo Corp. (4543:JP) (TRUMY) PT Raised to JPY2,700 at JPMorgan

Goldman Sachs Reiterates Neutral Rating on Terumo Corp. (4543:JP) (TRUMY)

Goldman Sachs Reiterates Neutral Rating on Terumo Corp. (4543:JP) (TRUMY)

Terumo Corp. (4543:JP) (TRUMY) PT Raised to JPY3,300 at Citi

Terumo Corp. (4543:JP) (TRUMY) PT Raised to JPY3,300 at Citi

Terumo Corp. (4543:JP) (TRUMY) PT Raised to JPY3,300 at Citi

Terumo Corp. (4543:JP) (TRUMY) PT Raised to JPY3,300 at Citi

OrganOx Announces Appointment of Naoya Iwata as CEO & President

OrganOx Announces Appointment of Naoya Iwata as CEO & President

OrganOx Announces Appointment of Naoya Iwata as CEO & President

OrganOx Announces Appointment of Naoya Iwata as CEO & President

OrganOx Announces Appointment of Naoya Iwata as CEO & President